1. Home
  2. MRUS vs WSFS Comparison

MRUS vs WSFS Comparison

Compare MRUS & WSFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • WSFS
  • Stock Information
  • Founded
  • MRUS 2003
  • WSFS 1980
  • Country
  • MRUS Netherlands
  • WSFS United States
  • Employees
  • MRUS N/A
  • WSFS N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • WSFS Major Banks
  • Sector
  • MRUS Health Care
  • WSFS Finance
  • Exchange
  • MRUS Nasdaq
  • WSFS Nasdaq
  • Market Cap
  • MRUS 2.7B
  • WSFS 2.7B
  • IPO Year
  • MRUS 2016
  • WSFS N/A
  • Fundamental
  • Price
  • MRUS $43.06
  • WSFS $47.94
  • Analyst Decision
  • MRUS Strong Buy
  • WSFS Hold
  • Analyst Count
  • MRUS 13
  • WSFS 4
  • Target Price
  • MRUS $86.85
  • WSFS $63.67
  • AVG Volume (30 Days)
  • MRUS 872.0K
  • WSFS 435.9K
  • Earning Date
  • MRUS 05-07-2025
  • WSFS 04-24-2025
  • Dividend Yield
  • MRUS N/A
  • WSFS 1.25%
  • EPS Growth
  • MRUS N/A
  • WSFS 0.23
  • EPS
  • MRUS N/A
  • WSFS 4.41
  • Revenue
  • MRUS $36,133,000.00
  • WSFS $984,948,000.00
  • Revenue This Year
  • MRUS $26.81
  • WSFS N/A
  • Revenue Next Year
  • MRUS $23.85
  • WSFS $4.04
  • P/E Ratio
  • MRUS N/A
  • WSFS $10.87
  • Revenue Growth
  • MRUS N/A
  • WSFS 6.26
  • 52 Week Low
  • MRUS $33.19
  • WSFS $41.33
  • 52 Week High
  • MRUS $61.61
  • WSFS $62.75
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 51.15
  • WSFS 43.27
  • Support Level
  • MRUS $33.19
  • WSFS $42.44
  • Resistance Level
  • MRUS $43.46
  • WSFS $50.11
  • Average True Range (ATR)
  • MRUS 3.53
  • WSFS 2.70
  • MACD
  • MRUS 0.34
  • WSFS -0.03
  • Stochastic Oscillator
  • MRUS 80.53
  • WSFS 53.19

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About WSFS WSFS Financial Corporation

WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.

Share on Social Networks: